Blood Test Evaluates Effectiveness of Skin Cancer Treatment
NYU Langone study shows a gene-based blood test may serve as an early indicator of treatment success in people with late-stage melanoma.
Molecular Biologist Explores the Mysteries of Immune Cells
NYU Langone molecular biologist Jane Skok untangles the secrets of DNA organization to improve treatments for some autoimmune diseases and blood cancers. Learn More.
Pig Kidney Xenotransplantation Optimal After 32 Days
The NYU Langone Transplant Institute transplanted a genetically engineered pig kidney into a human that has functioned optimally for over a month.
Scientists & Clinicians Plumb the Mysteries of a Novel Virus
Tapping its scientific resources and expertise, NYU Langone leads the effort to develop therapeutics and vaccines for COVID-19.
Treatment-Resistant Coronavirus Found in Transplant Patients
An NYU Langone study finds mutated coronavirus that can escape the antiviral therapy remdesivir in two people with kidney transplants.
Five IBD Symptoms You Should Never Ignore
NYU Langone gastroenterologist Dr. Ariela Holmer describes five symptoms of inflammatory bowel disease (IBD) that patients should not ignore.
dermatopathology-section-insurance.pdf
... EMPLOYEE CORPORATE PLAN UMR UNITED MEDICAL RESOURCES PPO UNICARE UNITED AARP MEDICARE COMPLETE ESSENTIAL ... as of January 2020 A AARP MEDICARE COMPLETE AETNA EMPLOYEE CORPORATE PLAN AETNA HMO AETNA INDEMNITY AETNA ...
NYU Langone Health in the News—April 18, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from April 18, 2025.
Baby’s Natural Bacteria Partly Restored After C-Section
By swabbing babies born by C-section with their mothers’ birth fluid, NYU Langone researchers partially restored the babies’ microbiomes.
Drug May Protect Ovaries & Fertility During Chemotherapy
NYU Langone study finds the drug everolimus keeps standard chemotherapy from depleting stores of cells needed for pregnancy in mice.